Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Teslac

Known as: Bristol Myers Squibb Brand of Testolactone, Bristol-Myers Squibb Brand of Testolactone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
To our knowledge, the action of estradiol which is produced from testosterone by aromatase on human spermatogenesis has not been… Expand
1986
1986
Summary:  Aromatase inhibition by Δ1 ‐testolactone (Teslac®, 500 mg twice daily) for 6 months in 9 patients with idiopathic… Expand
1982
1982
Aromatase inhibitor, 4-hydroxyandrostene-3,17-dione (4-OHA), is a highly effective treatment in rats with 7,12-dimethylbenz(a… Expand
1982
1982
Δ1-Testololactone (testolactone, 1-dehydrotestololactone, Teslac, 17 a-oxa-d-homo-1,4-androstadiene-3,17-dione) was tested in… Expand
Review
1981
Review
1981
Increased response rates with nonhormonal combination chemotherapy have led many oncologists to deprecate the use of hormonal… Expand
1981
1981
Ten men with idiopathic oligospermia were treated with delta 1-testolactone (Teslac), a potent inhibitor of conversion of… Expand